Trial Profile
A pilot study to evaluate hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 03 Dec 2015 New trial record